Trial
NCT01307605
Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular Lymphoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Swiss Cancer Institute
Collaborators
—
Condition
Lymphoma
Intervention
Rituximab
Why stopped
It was decided by the trial team to stop the collection of follow up data in trial SAKK 35/10.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-27